Richard A. Larson to Hypertension
This is a "connection" page, showing publications Richard A. Larson has written about Hypertension.
Connection Strength
0.282
-
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood. 2024 04 18; 143(16):1616-1627.
Score: 0.154
-
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202. Leukemia. 2021 10; 35(10):2854-2861.
Score: 0.128